Robert Grubb to Prostate
This is a "connection" page, showing publications Robert Grubb has written about Prostate.
Connection Strength
1.141
-
The REDUCE Follow-Up Study: low rate of new prostate cancer diagnoses observed during a 2-year, observational, followup study of men who participated in the REDUCE trial. J Urol. 2013 Mar; 189(3):871-7.
Score: 0.392
-
Signal pathway profiling of prostate cancer using reverse phase protein arrays. Proteomics. 2003 Nov; 3(11):2142-6.
Score: 0.211
-
Determination of the Role of Negative Magnetic Resonance Imaging of the Prostate in Clinical Practice: Is Biopsy Still Necessary? Urology. 2017 04; 102:190-197.
Score: 0.130
-
Accuracy analysis in MRI-guided robotic prostate biopsy. Int J Comput Assist Radiol Surg. 2013 Nov; 8(6):937-44.
Score: 0.101
-
Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures. J Proteome Res. 2009 Jun; 8(6):3044-54.
Score: 0.078
-
Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scanner. BJU Int. 2008 Jan; 101(2):181-5.
Score: 0.069
-
Repeat prostate biopsy in the prostate, lung, colorectal and ovarian cancer screening trial. BJU Int. 2007 Apr; 99(4):775-9.
Score: 0.066
-
Prostate volume and prostate-specific antigen levels in men enrolled in a large screening trial. Urology. 2006 Aug; 68(2):352-6.
Score: 0.064
-
Earlier prostate-specific antigen testing in African American men--Clinical support for the recommendation. Urol Oncol. 2015 Jul; 33(7):330.e9-17.
Score: 0.029